EP0250508A1 - Arzneimittel zur behandlung von leberkrankheiten - Google Patents

Arzneimittel zur behandlung von leberkrankheiten

Info

Publication number
EP0250508A1
EP0250508A1 EP19870900127 EP87900127A EP0250508A1 EP 0250508 A1 EP0250508 A1 EP 0250508A1 EP 19870900127 EP19870900127 EP 19870900127 EP 87900127 A EP87900127 A EP 87900127A EP 0250508 A1 EP0250508 A1 EP 0250508A1
Authority
EP
European Patent Office
Prior art keywords
medicament
liver
diseases
treatment
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870900127
Other languages
English (en)
French (fr)
Inventor
Ifeanyi Madubunyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAPE ESTABLISHMENT
Original Assignee
MAPE ESTABLISHMENT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAPE ESTABLISHMENT filed Critical MAPE ESTABLISHMENT
Publication of EP0250508A1 publication Critical patent/EP0250508A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19870900127 1985-12-16 1986-12-16 Arzneimittel zur behandlung von leberkrankheiten Withdrawn EP0250508A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853544457 DE3544457A1 (de) 1985-12-16 1985-12-16 Arzneimittel zur behandlung von leberkrankheiten
DE3544457 1985-12-16

Publications (1)

Publication Number Publication Date
EP0250508A1 true EP0250508A1 (de) 1988-01-07

Family

ID=6288568

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870900127 Withdrawn EP0250508A1 (de) 1985-12-16 1986-12-16 Arzneimittel zur behandlung von leberkrankheiten

Country Status (3)

Country Link
EP (1) EP0250508A1 (de)
DE (1) DE3544457A1 (de)
WO (1) WO1987003590A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE227569T1 (de) * 1995-06-23 2002-11-15 Advanced Life Sciences Inc Robustaflavon und dessen derivate als antivirales mittel
WO1998046238A1 (en) 1997-04-15 1998-10-22 Medichem Research, Inc. Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
US6677350B1 (en) 1999-09-22 2004-01-13 Advanced Life Sciences, Inc. Beta-fluoroethyl thiourea compounds and use
CN115894424B (zh) * 2023-01-06 2023-05-12 中日友好医院(中日友好临床医学研究所) 新型双黄酮类化合物及其制备方法、药物组合物和应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8703590A1 *

Also Published As

Publication number Publication date
DE3544457A1 (de) 1987-06-19
WO1987003590A1 (en) 1987-06-18

Similar Documents

Publication Publication Date Title
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
HUT42948A (en) Process for production of medical compositions suitable for transdermal treatment containing as active substance derivatives of 2-amin-3-aroil-benzol-acetic acid
AU1302388A (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides
CA2104531A1 (en) Antimicrobial Agent
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
NO881835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
ES539123A0 (es) Un compuesto de 3-indolcarboxamida
BE1002239A5 (fr) Solution pharmaceutique.
FR2450820A1 (fr) Nouveaux derives d'acides 1- (o-mercaptoacyl) -4,5-dihydropyrazole-5-carboxyliques, utiles notamment comme agents hypotenseurs, et leur procede de preparation
EP0250508A1 (de) Arzneimittel zur behandlung von leberkrankheiten
NO173137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser
EP0453574A4 (en) Cephalosporin derivative
IE832787L (en) Polyether compounds.
EP0446921A3 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ES8302008A1 (es) Un procedimiento para la preparacion de derivados de imidazo (2,1-b) tiazol.
HUT38920A (en) Process for producing anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thion derivatives
FR2395268A1 (fr) 3-thienyl-(3-methyl-4-pentyk-2-pyridyl)-cetone, utile notamment comme analgesique, et son procede de preparation
SU1556054A1 (ru) 4-(1-карбоксипентокси)-коричная кислота, обладающая гипотензивной активностью

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19870804

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

17Q First examination report despatched

Effective date: 19880809

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19901129

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MADUBUNYI, IFEANYI